ICM
DISCK

Invenomic Capital Management’s Discovery, Inc. Series C Common Stock DISCK Stock Holding History

Invenomic Capital Management’s Portfolio DISCK Stock Details DISCK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-330,078
Closed -$6.83M – 199
2022
Q1 		$6.83M Buy
330,078
+120,609
+58% +$3.27M 0.73% 41
2021
Q4 		$4.8M Buy
209,469
+40,613
+24% +$978K 1.03% 34
2021
Q3 		$4.1M Buy
168,856
+38,424
+29% +$1.03M 1.33% 26
2021
Q2 		$3.78M Buy
130,432
+115,657
+783% +$3.59M 0.91% 23
2021
Q1 		$546K Sell
14,775
-79,356
-84% -$3.37M 0.12% 96
2020
Q4 		$2.47M Sell
94,131
-49,563
-34% -$1.09M 0.63% 29
2020
Q3 		$2.82M Buy
143,694
+31,867
+28% +$629K 1.55% 10
2020
Q2 		$2.15M Hold
111,827
– – 1.59% 13
2020
Q1 		$1.96M Sell
111,827
-68,850
-38% -$1.78M 1.6% 16
2019
Q4 		$5.51M Buy
+180,677
New +$5.07M 2.21% 6

Other funds holding DISCK

HBCM
Heron Bay Capital Management Bloomfield Hills, Michigan $1.08B AUM 7.99% 1-Year Est. Return
DIS
Diversified Investment Strategies Baton Rouge, Louisiana $157M AUM 24.09% 1-Year Est. Return
SCA
Sage Capital Advisors Sioux Falls, South Dakota $482M AUM 34.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
OPA
Old Port Advisors Portland, Maine $508M AUM 50.99% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
ACA
Atlas Capital Advisors Jackson, Wyoming $875M AUM
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Invenomic Capital Management's DISCK Position: Q2 2022 in Review

Invenomic Capital Management sold out of Discovery, Inc. Series C Common Stock (DISCK) in Q2 2022, closing a stake of 330,078 shares — an estimated $6.83M sold.

Invenomic Capital Management first reported a position in DISCK in Q4 2019 and held it in 10 quarters. The position peaked at $6.83M in Q1 2022. 9 funds tracked by Wall St. Rank hold DISCK as of Q2 2022.

  • Invenomic Capital Management reported no remaining Discovery, Inc. Series C Common Stock position as of Q2 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 330,078 Discovery, Inc. Series C Common Stock shares in Q2 2022, an estimated $6.83M.
  • Invenomic Capital Management first reported a position in Discovery, Inc. Series C Common Stock in Q4 2019 and held it in 10 quarters.
  • Invenomic Capital Management's Discovery, Inc. Series C Common Stock position peaked at $6.83M in Q1 2022.
  • 9 funds tracked by Wall St. Rank held Discovery, Inc. Series C Common Stock as of Q2 2022.

Based on Invenomic Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.